SynapCell is involved in the funded EU Project NEURINOX. Together with the project consortium, we will be hosting a symposium on Innovative Concepts for Treating Neurodegenerative Diseases. This will be held over the 23rd and 24th September at the Molecular Biotechnology Centre in Torino (Italy), with a focus on ALS (Lou Gehrig Disease), epilepsy and multiple sclerosis.

The event is addressed to scientists, patient groups and the pharmaceutical industry. Day1 will mainly address the 3 main diseases for those interested in the topic: patients associations, students, journalists; while Day 2 will be devoted to scientific and industrial communities, focusing on Disease pathophysiology, Biomarker discovery and personalized medicine, development of new therapies.